Top Stories

Grid List

GlaxoSmithKline plc and Innoviva, Inc announced the presentation of further data from the pivotal phase III FULFIL study with investigational closed triple combination therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI 100/62.5/25 mcg).

At the signing ceremony of the new research collaboration: Back row from left: Dr. Simone Gatzke, Forschungszentrum Juelich, Raphael Dumain, Dr. Isolde Häuser-Hahn and Dr. habil Guenter Welz from Bayer, Prof. Ulrich Schurr, Juelich, Dr. Samir Bennabi, Bayer.

Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, and Saniona, a leading biotech company in the field of ion channel drug discovery, announced that they have entered into a research collaborationwith the objective to discover and develop novel compounds for the treatment of schizophrenia.

Advaxis, Inc a clinical stage biotechnology company developing cancer immunotherapies, will unveil its new state-of-the-art manufacturing facility in Princeton, N.J., with remarks from Governor Chris Christie, BioNJ President and CEO Debbie Hart and Advaxis CEO Daniel O’Connor.

Results from pivotal Phase III trials presented at the ERS International Congress demonstrated that adding benralizumab to standard-of-care medicine significantly reduced exacerbations and improved lung function and asthma symptoms in severe asthma patients with an eosinophilic phenotype, as indicated by the presence of eosinophils in their blood.

CiToxLAB, a leading CRO in the field of non-clinical research, announces that Alan Bartlett has joined the company as Senior Director, Global Laboratory Operations, bringing with him 30 years’ experience in the development and implementation of laboratory support in preclinical and clinical research.

Dr. Reddy’s Laboratories Ltd announced that it has launched Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg, a therapeutic equivalent generic version of Wellbutrin® SR (bupropion HCl) Sustained-Release Tablets in the United States market approved by the U.S. FDA.

Preliminary data from the world’s first national meningitis B immunisation programme with Bexsero1, launched one year ago in the UK, shows the estimated effectiveness of the vaccine at 83 percent against any meningitis B strain and 94 percent.

AstraZeneca announced that it has completed the commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anaesthetics portfolio outside the US.

Bizerba’s solution portfolio now includes filling systems as well. Following the merger with Busch, a Swiss company, the weighing specialist now integrates competencies in filling technology into the companies’ joint portfolio. Bizerba’s fully and semi-automatic filling solutions target the chemical, food, building material, paint and lacquer and pharmaceutical industries.

Wipak Distinctly Different Sustainable Laminate Solutions, including new and innovative applications of paper and plastic laminates for cheese, sausages and more.

Perigord, innovators in Life Science Artwork Management Services and Solutions, and GlobalVision, leaders in the design and delivery of Innovative Proofreading Technologies announced their alliance for the integration of their artwork management systems in order to better service the Life Science Industries.

Market Movers

Rogers Corporation Common Stock

NYQ : ROG - 28 Sep, 4:02pm
+0.14 (+0.23%) After Hours:
Open 61.00 Mktcap 1.10B
High 61.13 52wk Hight 69.26
Low 60.26 52wk Low 41.92
Vol 107985 Avg Vol 133689
Eps 0.00 P/e 28.25
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 28 Sep, 4:02pm
+0.08 (+1.84%) After Hours:
Open 4.41 Mktcap 70.77B
High 4.43 52wk Hight 6.06
Low 4.35 52wk Low 3.60
Vol 4.91M Avg Vol 6.37M
Eps 0.39 P/e 13.55
Currency: USD

Merck & Company, Inc. Common St

NYQ : MRK - 28 Sep, 4:00pm
+0.73 (+1.17%) After Hours:
Open 63.00 Mktcap 175.04B
High 63.48 52wk Hight 64.00
Low 62.49 52wk Low 47.97
Vol 11.79M Avg Vol 9.60M
Eps 3.75 P/e 34.72
Currency: USD

Johnson & Johnson Common Stock

NYQ : JNJ - 28 Sep, 4:00pm
+0.17 (+0.14%) After Hours:
Open 119.05 Mktcap 326.64B
High 119.52 52wk Hight 126.07
Low 118.81 52wk Low 91.76
Vol 5.08M Avg Vol 6.35M
Eps 6.69 P/e 22.25
Currency: USD

Pfizer, Inc. Common Stock

NYQ : PFE - 28 Sep, 4:00pm
+0.16 (+0.47%) After Hours:
Open 33.85 Mktcap 206.17B
High 34.00 52wk Hight 37.39
Low 33.69 52wk Low 28.25
Vol 14.31M Avg Vol 19.17M
Eps 2.46 P/e 30.13
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 28 Sep, 4:00pm
+0.00 (+0.00%) After Hours:
Open Mktcap
High 13.02 52wk Hight 17.45
Low 52wk Low 12.60
Vol 65 Avg Vol 9436
Eps P/e
Currency: USD
Sign up via our free email subscription service to receive notifications when new information is available.

In announcing the result, Amcor’s Managing Director & CEO, Mr Ron Delia said: “, Amcor reported a strong full year result with growth in earnings, returns and cash flow delivered in a challenging macroeconomic environment.

Sonoco ThermoSafe has acquired the PharmaPort 360™ assets, licenses, trademarks and manufacturing rights from AAR, to enter the active temperature-controlled cargo containers market.

The global rigid film producer Klöckner Pentaplast will acquire Farmamak Review from Venture Capital Investment Trust Inc. (Review Initiative). Farmamak will operat on as a subsidiary within the Klöckner Pentaplast Group. 

Videojet launches new solvent ink with enhanced adhesion on non-porous consumer packaged goods

Getting the most out of processing and packagingmachinery through comprehensive training
Most up-to-date processing andpackaging machinery play an important role in succeeding in the pharmaceutical industry. But even the newest equipment cannot unlock its full potential when it is not handled and maintained the right way.

How the once-conservative pharmaceutical companies are learning from the FMCG industry
The days of the patent-protected blockbusters among the pharma giants are behind us, and the realities of demographic shifts, spiraling healthcare costs, global economic crises and generics growth are causing the whole industry to re-think the traditional business models.

Amgen will present at the Morgan Stanley Global Healthcare Conference at 10:30 a.m. ET on Wednesday, Sept. 14, 2016, in New York City. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference.

Teva Pharmaceutical Industries Ltd. announced that it will host a conference call and live webcast along with a slide presentation on Friday, September 9, 2016 at 8:00 a.m. ET to communicate an overview of the future prospects of Teva Generics business following the close of the Actavis generics deal.

Teva Pharmaceutical Industries Ltd will host a live audio webcast at the Wells Fargo Healthcare Conference. Eyal Desheh will present on Wednesday, September 7, 2016 at 1:10 PM ET.

Monthly E-Newsletter

Teline V